Salt Lake Life Science Angels Leads Financing in Wasatch Microfluidics

Salt Lake City, UT - September 26, 2007 - Salt Lake Life Science Angels (SLLSA) announced today that it has led an investment in Wasatch Microfluidics LLC, an early stage company developing microfluidic technologies. SLLSA was joined in the financing round by investors from the Utah Angels.

About SLLSA:
SLLSA is a Salt Lake City-based angel investment group that was founded in 2006 to facilitate investment in seed-stage life science companies in Utah and the surrounding region. SLLSA is made up of accredited executives, entrepreneurs, scientists, and clinicians seeking investment opportunities in early-stage companies.

Sponsors of SLLSA include: the Parr Waddoups Brown Gee & Loveless Business Transactions Group, the Stoel Rives Technology & Intellectual Property Practice Group, Wasatch Venture Fund, and the Utah Fund of Funds.

For additional information regarding SLLSA, please visit www.SLLSA.com.

About Wasatch Microfluidics:
Wasatch Microfluidics is a development stage company with proprietary microfluidic technologies for biological sample processing, microarray printing, high sensitivity drug discovery assays, and high-throughput diagnostics. Wasatch's technology was developed at the University of Utah by company founder Dr. Bruce Gale. He developed the technology in conjunction with Dr. David Myszka, a world-renowned protein interaction researcher at the University of Utah.

For more information about Wasatch Microfluidics, please visit www.microfl.com.

Contacts:
Andrew Laver, Managing Director
Salt Lake Life Science Angels
(801) 308-1001

Gary Sams, CEO
Wasatch MicroFluidics
(619) 838-4882

###